A Novel Ureteric Stent in Kidney Stone Patients and Oncology Patients Compared to a Conventional JJ Stent
Recruiting now · Not applicable
Conditions studied: Catheter Blockage, Oncology, Kidney Stone
In brief
Urological stents and catheters often lead to inflammation, causing pain and infection in the urinary tract. Moreover, 80% of stents are associated with pain, negatively impacting on QoL and mental health. Offering novel designs with significantly lower E\&B leads to a reduction in UTIs and improves QoL. Reducing hospital admissions (from 3 to 1 per patient, annually) would free \>100,000 bed-nights, allowing the elderly to regain independence. Our proposed research could have a significant impact towards fulfilling the 'healthy-ageing' Grand Challenge. Additionally, the novel stent reduces prevalence of infections and therefore, of antibiotic prescriptions contributing to the Global AMR challenge.
Key facts
- Study ID
- NCT06815120
- Run by
- University of Southampton
- People needed
- 50
- Starts
- 2025-08-06
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2026-05-11
Who can join
Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Aged 18 years or over
- Ureteric stents clinically indicated either due to kidney stones or abdominal/pelvic cancers compressing ureters
- Previous experience with ureteric stents
- Awaiting insersion/replacement of stents
- Ability to give consent
- Ability to interact with study documentation
- Sufficient English to complete study documentations and questionnaires
You may not qualify if…
- Expected survival <4months
- Unfit for stent insertion
- Unable to comply with study processes Pregnancy
Where it is running
- University Hospital Southampton — Southampton, England, United Kingdom (enrolling)
- University College Hospital London — London, London, United Kingdom (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.